Position in BIIB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$95,941,226
+$34,756,856 QoQ
Shares Held
444,049
+33.1% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#43
of 1,036 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. BIIB ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
This page
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
|
184,693 | $46,906,481 |
All Filings in BIIB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,941,226 | 444,049 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $61,184,370 | 333,739 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $55,756,271 | 316,815 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $42,982,007 | 306,839 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $31,643,530 | 251,959 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $33,111,995 | 241,976 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $35,851,788 | 234,448 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,044,360 | 41,500 | Shares | Sole | 2024-11-12 | |
| 2023-12-31 | $30,283,853 | 117,030 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $88,579,010 | 344,652 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $100,672,826 | 353,424 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $101,885,205 | 366,454 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $99,373,849 | 358,854 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $98,555,574 | 369,122 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $75,549,980 | 370,452 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $78,690,690 | 373,650 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $85,176,878 | 355,022 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $102,329,749 | 361,602 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $124,716,065 | 360,170 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $256,847,147 | 918,131 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $229,762,177 | 938,341 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $280,585,618 | 989,092 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $269,625,652 | 1,007,758 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $340,069,585 | 1,074,877 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||